Literature DB >> 16227249

N-linked glycosylation of west nile virus envelope proteins influences particle assembly and infectivity.

Sheri L Hanna1, Theodore C Pierson, Melissa D Sanchez, Asim A Ahmed, Mariam M Murtadha, Robert W Doms.   

Abstract

West Nile virus (WNV) encodes two envelope proteins, premembrane (prM) and envelope (E). While the prM protein of all WNV strains contains a single N-linked glycosylation site, not all strains contain an N-linked site in the E protein. The presence of N-linked glycosylation on flavivirus E proteins has been linked to virus production, pH sensitivity, and neuroinvasiveness. Therefore, we examined the impact of prM and E glycosylation on WNV assembly and infectivity. Similar to other flaviviruses, expression of WNV prM and E resulted in the release of subviral particles (SVPs). Removing the prM glycosylation site in a lineage I or II strain decreased SVP release, as did removal of the glycosylation site in a lineage I E protein. Addition of the E protein glycosylation site in a lineage II strain that lacked this site increased SVP production. Similar results were obtained in the context of either reporter virus particles (RVPs) or infectious lineage II WNV. RVPs or virions bearing combinations of glycosylated and nonglycosylated forms of prM and E could infect mammalian, avian, and mosquito cells (BHK-21, QT6, and C6/36, respectively). Those particles lacking glycosylation on the E protein were modestly more infectious per genome copy on BHK-21 and QT6 cells, while this absence greatly enhanced the infection of C6/36 cells. Thus, glycosylation of WNV prM and E proteins can affect the efficiency of virus release and infection in a manner that is cell type and perhaps species dependent. This suggests a multifaceted role for envelope N-linked glycosylation in WNV biology and tropism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227249      PMCID: PMC1262570          DOI: 10.1128/JVI.79.21.13262-13274.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  Alpha-glucosidase inhibitors reduce dengue virus production by affecting the initial steps of virion morphogenesis in the endoplasmic reticulum.

Authors:  M P Courageot; M P Frenkiel; C D Dos Santos; V Deubel; P Desprès
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins.

Authors:  A K Falconar
Journal:  Arch Virol       Date:  1999       Impact factor: 2.574

3.  Structure of West Nile virus.

Authors:  Suchetana Mukhopadhyay; Bong-Suk Kim; Paul R Chipman; Michael G Rossmann; Richard J Kuhn
Journal:  Science       Date:  2003-10-10       Impact factor: 47.728

4.  Phylogeny of the genus Flavivirus.

Authors:  G Kuno; G J Chang; K R Tsuchiya; N Karabatsos; C B Cropp
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

5.  Changes in the dengue virus major envelope protein on passaging and their localization on the three-dimensional structure of the protein.

Authors:  E Lee; R C Weir; L Dalgarno
Journal:  Virology       Date:  1997-06-09       Impact factor: 3.616

6.  Viral envelope protein glycosylation is a molecular determinant of the neuroinvasiveness of the New York strain of West Nile virus.

Authors:  Kazuya Shirato; Hirotsugu Miyoshi; Akiko Goto; Yoshihiko Ako; Tomotaka Ueki; Hiroaki Kariwa; Ikuo Takashima
Journal:  J Gen Virol       Date:  2004-12       Impact factor: 3.891

7.  Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR.

Authors:  George Lin; Graham Simmons; Stefan Pöhlmann; Frédéric Baribaud; Houping Ni; George J Leslie; Beth S Haggarty; Paul Bates; Drew Weissman; James A Hoxie; Robert W Doms
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

8.  Partial genetic characterization of West Nile virus strains, New York State, 2000.

Authors:  G D Ebel; A P Dupuis; K Ngo; D Nicholas; E Kauffman; S A Jones; D Young; J Maffei; P Y Shi; K Bernard; L D Kramer
Journal:  Emerg Infect Dis       Date:  2001 Jul-Aug       Impact factor: 6.883

9.  Phylogenetic relationships of southern African West Nile virus isolates.

Authors:  Felicity J Burt; Antoinette A Grobbelaar; Patricia A Leman; Fiona S Anthony; Georgina V F Gibson; Robert Swanepoel
Journal:  Emerg Infect Dis       Date:  2002-08       Impact factor: 6.883

10.  Experimental infection of North American birds with the New York 1999 strain of West Nile virus.

Authors:  Nicholas Komar; Stanley Langevin; Steven Hinten; Nicole Nemeth; Eric Edwards; Danielle Hettler; Brent Davis; Richard Bowen; Michel Bunning
Journal:  Emerg Infect Dis       Date:  2003-03       Impact factor: 6.883

View more
  109 in total

1.  Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulence.

Authors:  Brian C Keller; Brenda L Fredericksen; Melanie A Samuel; Richard E Mock; Peter W Mason; Michael S Diamond; Michael Gale
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

Review 2.  Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion.

Authors:  Melanie A Samuel; Michael S Diamond
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

3.  West Nile virus genome with glycosylated envelope protein and deletion of alpha helices 1, 2, and 4 in the capsid protein is noninfectious and efficiently secretes subviral particles.

Authors:  Justin A Roby; Roy A Hall; Alexander A Khromykh
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

4.  Requirement of glycosylation of West Nile virus envelope protein for infection of, but not spread within, Culex quinquefasciatus mosquito vectors.

Authors:  Robin M Moudy; Anne F Payne; Brittany L Dodson; Laura D Kramer
Journal:  Am J Trop Med Hyg       Date:  2011-08       Impact factor: 2.345

5.  West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection.

Authors:  Carl W Davis; Hai-Yen Nguyen; Sheri L Hanna; Melissa D Sánchez; Robert W Doms; Theodore C Pierson
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

6.  Temperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation.

Authors:  Camilo Ansarah-Sobrinho; Steevenson Nelson; Christiane A Jost; Stephen S Whitehead; Theodore C Pierson
Journal:  Virology       Date:  2008-09-17       Impact factor: 3.616

7.  The infectivity of prM-containing partially mature West Nile virus does not require the activity of cellular furin-like proteases.

Authors:  Swati Mukherjee; Tsai-Yu Lin; Kimberly A Dowd; Carolyn J Manhart; Theodore C Pierson
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

8.  Differential effects of mutations in NS4B on West Nile virus replication and inhibition of interferon signaling.

Authors:  Jared D Evans; Christoph Seeger
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

9.  Role of N-linked glycosylation for sindbis virus infection and replication in vertebrate and invertebrate systems.

Authors:  Ronald L Knight; Kimberly L W Schultz; Rebekah J Kent; Meera Venkatesan; Diane E Griffin
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

10.  Mouse embryonic stem cells are deficient in type I interferon expression in response to viral infections and double-stranded RNA.

Authors:  Ruoxing Wang; Jundi Wang; Amber M Paul; Dhiraj Acharya; Fengwei Bai; Faqing Huang; Yan-Lin Guo
Journal:  J Biol Chem       Date:  2013-04-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.